1. |
Takano M, Kishi S. Foveal retinoschisis and retinal detachment in severely myopic eyes with posterior staphyloma[J]. Am J Ophthalmol, 1999, 128(4): 472-476. DOI: 10.1016/s0002-9394(02)01937-2.
|
2. |
Ho TC, Yang CM, Huang JS, et al. Long-term outcome of foveolar internal limiting membrane nonpeeling for myopic traction maculopathy[J]. Retina, 2014, 34(9): 1833-1840. DOI: 10.1097/IAE.0000000000000149.
|
3. |
Elwan MM, Abd Elghafar AE, Hagras SM, et al. Long-term outcome of internal limiting membrane peeling with and without foveal sparing in myopic foveoschisis[J]. Eur J Ophthalmol, 2019, 29(1): 69-74. DOI: 10.1177/1120672117750059.
|
4. |
朱丽, 陈晓, 晏颖, 等. 玻璃体切割联合内界膜完全剥除和保留中心凹内界膜剥除手术治疗高度近视黄斑劈裂的疗效比较[J]. 中华眼底病杂志, 2020, 36(7): 509-513. DOI: 10.3760/cma.j.cn511434-20200102-00001.Zhu L, Chen X, Yan Y, et al. Comparison of the efficacy of vitrectomy combined with complete internal limiting membrane peeling and fovea-sparing internal limiting membrane peeling for high myopia macular foveoschisis[J]. Chin J Ocul Fundus Dis, 2020, 36(7): 509-513. DOI: 10.3760/cma.j.cn511434-20200102-00001.
|
5. |
应佳, 李俊, 徐格致, 等. 玻璃体切除联合内界膜剥除术治疗高度近视眼黄斑劈裂的疗效观察[J]. 中华眼科杂志, 2020, 56(12): 928-932. DOI: 10.3760/cma.j.cn112142-20200319-00204.Ying J, Li J, Xu GZ, et al. Therapeutic effects of pars plana vitrectomy combined with internal limiting membrane peeling on high myopic foveoschisis[J]. Chin J Ophthalmol, 2020, 56(12): 928-932. DOI: 10.3760/cma.j.cn112142-20200319-00204.
|
6. |
Shiraki N, Wakabayashi T, Ikuno Y, et al. Fovea-sparing versus standard internal limiting membrane peeling for myopic traction maculopathy: a study of 102 consecutive cases[J]. Ophthalmol Retina, 2020, 4(12): 1170-1180. DOI: 10.1016/j.oret.2020.05.016.
|
7. |
Itoh Y, Inoue M, Kato Y, et al. Alterations of foveal architecture during vitrectomy for myopic retinoschisis identified by intraoperative optical coherence tomography[J]. Ophthalmologica, 2019, 242(2): 87-97. DOI: 10.1159/000500362.
|
8. |
Iwasaki M, Miyamoto H, Okushiba U, et al. Fovea-sparing internal limiting membrane peeling versus complete internal limiting membrane peeling for myopic traction maculopathy[J]. Jpn J Ophthalmol, 2020, 64(1): 13-21. DOI: 10.1007/s10384-019-00696-1.
|
9. |
王艳辉, 张胜娟, 李云环, 等. 25G微创玻璃体切除联合完全内界膜剥除与联合保留中心凹处内界膜剥除术治疗高度近视黄斑劈裂的效果比较[J]. 临床眼科杂志, 2018, 26(5): 385-389. DOI: 10.3969/j.issn.1006-8422.2018.05.001.Wang YH, Zhang SJ, Li YH, et al. Comparison of the effect of 25G vitrectomy with internal limiting membrane peeling and with fovea-sparing internal limiting membrane peeling for myopic foveoschisis[J]. J Clin Ophthalmol, 2018, 26(5): 385-389. DOI: 10.3969/j.issn.1006-8422.2018.05.001.
|
10. |
Tian T, Jin H, Zhang Q, et al. Long-term surgical outcomes of multiple parfoveolar curvilinear internal limiting membrane peeling for myopic foveoschisis[J]. Eye (Lond), 2018, 32(11): 1783-1789. DOI: 10.1038/s41433-018-0178-0.
|
11. |
Shimada N, Sugamoto Y, Ogawa M, et al. Fovea-sparing internal limiting membrane peeling for myopic traction maculopathy[J]. Am J Ophthalmol, 2012, 154(4): 693-701. DOI: 10.1016/j.ajo.2012.04.013.
|
12. |
Gohil R, Sivaprasad S, Han LT, et al. Myopic foveoschisis: a clinical review[J]. Eye (Lond), 2015, 29(5): 593-601. DOI: 10.1038/eye.2014.311.
|
13. |
Azuma K, Hirasawa K, Araki F, et al. Fovea-sparing as opposed to total peeling of internal limiting membrane for myopic foveoschisis: a systematic review and meta-analysis[J]. Ophthalmol Retina, 2021, 5(7): 670-679. DOI: 10.1016/j.oret.2020.10.010.
|
14. |
Kumagai K, Furukawa M, Ogino N, et al. Factors correlated with postoperative visual acuity after vitrectomy and internal limiting membrane peeling for myopic foveoschisis[J]. Retina, 2010, 30(6): 874-880. DOI: 10.1097/IAE.0b013e3181c703fc.
|
15. |
Gui J, Ai L, Huang T. Vitrectomy with or without internal limiting membrane peeling for myopic foveoschisis[J]. BMC Ophthalmol, 2020, 20(1): 83. DOI: 10.1186/s12886-020-01354-8.
|
16. |
Jin H, Zhang Q, Zhao P. Fovea sparing internal limiting membrane peeling using multiple parafoveal curvilinear peels for myopic foveoschisis: technique and outcome[J]. BMC Ophthalmol, 2016, 16(1): 180. DOI: 10.1186/s12886-016-0356-4.
|
17. |
Kim KS, Lee SB, Lee WK. Vitrectomy and internal limiting membrane peeling with and without gas tamponade for myopic foveoschisis[J]. Am J Ophthalmol, 2012, 153(2): 320-326. DOI: 10.1016/j.ajo.2011.07.007.
|
18. |
Gao X, Ikuno Y, Fujimoto S, et al. Risk factors for development of full-thickness macular holes after pars plana vitrectomy for myopic foveoschisis[J]. Am J Ophthalmol, 2013, 155(6): 1021-1027. DOI: 10.1016/j.ajo.2013.01.023.
|
19. |
Sisk RA, Toygar O. Full-thickness macular hole formation after internal limiting membrane peeling: beware the "Omega Sign"[J/OL]. Case Rep Ophthalmol Med, 2016, 2016: 9858291[2016-09-25]. https://pubmed.ncbi.nlm.nih.gov/27747120/. DOI: 10.1155/2016/9858291.
|
20. |
Lee CL, Wu WC, Chen KJ, et al. Modified internal limiting membrane peeling technique (maculorrhexis) for myopic foveoschisis surgery[J]. Acta Ophthalmol, 2017, 95(2): 128-131. DOI: 10.1111/aos.13115.
|
21. |
Wang L, Wang Y, Li Y, et al. Comparison of effectiveness between complete internal limiting membrane peeling and internal limiting membrane peeling with preservation of the central fovea in combination with 25G vitrectomy for the treatment of high myopic foveoschisis[J/OL]. Medicine (Baltimore), 2019, 98(9): e14710[2019-03-01]. https://pubmed.ncbi.nlm.nih.gov/30817612/. DOI: 10.1097/MD.0000000000014710.
|
22. |
Yun LN, Xing YQ. Long-term outcome of highly myopic foveoschisis treated by vitrectomy with or without gas tamponade[J]. Int J Ophthalmol, 2017, 10(9): 1392-1395. DOI: 10.18240/ijo.2017.09.10.
|
23. |
Panozzo G, Mercanti A. Vitrectomy for myopic traction maculopathy[J]. Arch Ophthalmol, 2007, 125(6): 767-772. DOI: 10.1001/archopht.125.6.767.
|